Skip to main content

Table 3 Wound repair rate (%) after different TESE grafting in a time manner

From: Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent

 

3 days

6 days

9 days

12 days

15 days

18 days

No cell

19.77 ± 2.46

29.31 ± 7.46

41.34 ± 8.22

59.57 ± 3.10

69.05 ± 2.26

79.38 ± 0.76

Fibroblasts

23.14 ± 4.28

34.09 ± 3.81

50.87 ± 2.34

66.85 ± 4.98

80.5 ± 3.10

92.92 ± 1.96

eMSCs

20.71 ± 1.66

36.12 ± 1.02

53.32 ± 1.98

71.91 ± 2.63

77.01 ± 0.52

89.20 ± 0.71

pMSCs

19.70 ± 3.23

30.86 ± 7.14

50.59 ± 6.03

69.25 ± 4.12

80.06 ± 2.74

90.20 ± 0.78

  1. Data presented as mean ± SD
  2. eMSC mesenchymal stem cell derived from embryonic stem cell, pMSC mesenchymal stem cell derived from parthenogenetic embryonic stem cell, TESE tissue-engineered skin equivalents